InnoCare Pharma Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
711.00
-485.00
-706.00
-1,028.00
-24.00
-440.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-682.00
-20.00
-268.00
-8.00
192.00
-112.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
221.00
-251.00
-604.00
-456.00
297.00
-294.00
Cash Flow from Investing Activities
-398.00
1,059.00
599.00
-2,209.00
-2,161.00
-1,276.00
Cash Flow from Financing Activities
-36.00
-309.00
1.00
3,598.00
3,067.00
2,514.00
Net Cash Inflow / Outflow
-281.00
517.00
24.00
1,096.00
1,147.00
781.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-67.00
18.00
28.00
162.00
-54.00
-161.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of InnoCare Pharma Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
711.378900046849
2738.14442927314
-2,027.00
-74.02%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-682.268794735367
-1135.92614066269
453.00
39.94%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
221.715840907985
4552.50846025193
-4,331.00
-95.13%
Cash Flow from Investing Activities
-398.613678938185
-3469.87951101544
3,071.00
88.51%
Cash Flow from Financing Activities
-36.5620020958881
-1265.34668807144
1,229.00
97.11%
Net Cash Inflow / Outflow
-281.399676455441
-152.371397706976
-129.00
-84.68%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-67.9398363293525
30.3463411279792
-97.00
-323.88%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 188.22% vs 58.40% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
221.72
-251.32
188.22%






